PT21 SOLUTIONS LIMITED

Financial Health Score: D- (Vulnerable)

Explanation: PT21 Solutions Limited is exhibiting symptoms of chronic financial atrophy. While the company’s immediate liquidity (its "pulse") remains stable and it is current on its regulatory filings, it has suffered a severe, multi-year hemorrhage of equity. Since its peak financial condition in 2018, the business has experienced a consistent and dramatic loss of net assets, dropping from a healthy £63,670 to a dangerously thin £5,157. The patient is surviving, but its financial immune system is severely compromised, leaving it highly vulnerable to any external economic shock.

Key Vital Signs

• Net Assets (Financial Blood Pressure): £5,157 (Down 92% since 2018) Net assets represent the company's financial reserves or "blood pressure." A healthy reading grows over time. For PT21 Solutions, this metric has been falling steadily and aggressively. The drop from £63,670 in 2018 to just £5,157 indicates that the business has been bleeding value and retained earnings for six consecutive years, leaving it with dangerously low financial reserves.
• Current Ratio (Financial Pulse): 1.62 (£12,193 / £7,533) The current ratio measures short-term liquidity—how easily the company can pay its immediate bills. A ratio of 1.62 means the company has £1.62 in short-term assets for every £1 of short-term debt. While not critical, this pulse is barely robust. It indicates the company can cover its immediate obligations, but it lacks the working capital "energy" needed to comfortably fund growth.
• Liabilities (Financial Cholesterol): £7,533 (Stagnant) Current liabilities have remained perfectly static at £7,533 for both 2023 and 2024. While this means the company isn't taking on dangerous new debt, it also suggests a stagnation in business activity—like a patient whose cholesterol isn't worsening, but who also isn't clearing the blockage.
• Fixed Assets (Bone Density): £1,151 (Down from £1,536) Fixed assets represent the long-term structural strength of the business. At just £1,151, the company has very little in the way of physical or structural investments. The vast majority of its assets are current (likely cash or amounts owed by debtors), meaning the business is operating in a very lean, perhaps fragile, manner.

Diagnosis: Chronic Financial Atrophy

The financial data reveals a business that is suffering from chronic financial atrophy—a progressive wasting away of its financial muscle.

Looking at the medical history (financial trajectory), the patient was at peak health in 2018 with £85,303 in total assets and £63,670 in net assets. Since then, there has been a relentless, year-on-year decline. By 2024, total assets have shrunk by nearly 85% to £13,344.

Because the company files as a micro-entity, we cannot see the detailed Profit & Loss statement (the "blood work" showing revenue versus expenses), but the balance sheet tells a clear story: the business is consistently spending more than it earns, gradually consuming its own equity to survive. The P&L reserve has been drained, and the company is now operating with a net asset base of just over £5,000.

The condition is currently stable but critical. The company is not insolvent—it has more assets than liabilities and can pay its immediate debts. However, with such a thin layer of equity, even a minor unexpected expense (a "health emergency") could push the company into a state of financial distress.

Recommendations: Prescriptions for Financial Wellness

To restore this patient to health, the following immediate interventions are required:

1. Stop the Bleeding (Revenue and Margin Review): The priority is to halt the drain on net assets. Conduct an immediate review of overhead costs and pricing strategies. The business must return to profitability; it cannot afford to continue subsidizing trading losses from its remaining capital.
2. Clear the Arterial Plaque (Liability Reduction): The static £7,533 in current liabilities needs to be addressed. Whether this is an overdue trade payable, a director's loan, or a tax accrual, clearing this debt will free up working capital, improve the current ratio, and provide the business with more financial "breathing room."
3. Build Financial Muscle (Cash Reserves): With only £5,157 in net assets backing a business that has been running for 15 years, the financial immune system is practically non-existent. Target a specific percentage of future revenue to be retained in the business rather than distributed, aiming to rebuild the net asset base back up to at least £20,000 to create a buffer against future shocks.
4. Compliance Health Check: The accounts were signed off by Directors Odi and Olukolu in April 2025, and the company is up to date with Companies House. This is a positive sign of administrative health. Ensure that the four People with Significant Control are aligned on the recovery strategy, as turning this business around will require a coordinated effort from all directors and shareholders.